Similar findings have also recently been reported in acute myeloid leukaemia by Wellbrock et al. with high levels of GLI1 or GLI2 identified as negative prognostic markers and direct inhibition of GLI1/2 exerting antileukaemic effects34. This evidence concerns the gene GLI2 and acute myeloid leukemia.